Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
114.23
+1.81 (1.61%)
Dec 20, 2024, 4:00 PM EST - Market closed
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $10.64B in the quarter ending September 30, 2024, with 4.85% growth. This brings the company's revenue in the last twelve months to $41.22B, up 3.15% year-over-year. In the year 2023, Abbott Laboratories had annual revenue of $40.11B, down -8.12%.
Revenue (ttm)
$41.22B
Revenue Growth
+3.15%
P/S Ratio
4.82
Revenue / Employee
$361,553
Employees
114,000
Market Cap
198.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
Dec 31, 2019 | 31.90B | 1.33B | 4.34% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck & Co. | 63.17B |
Pfizer | 59.38B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher | 42.37B |
Amgen | 32.53B |
Danaher | 23.74B |
ABT News
- 7 hours ago - Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline - Seeking Alpha
- 4 days ago - Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart - PRNewsWire
- 7 days ago - Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value - Seeking Alpha
- 8 days ago - Abbott Increases Quarterly Dividend for 53rd Consecutive Year - PRNewsWire
- 13 days ago - University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott - PRNewsWire
- 24 days ago - The Best Large-Cap Stocks to Buy - Kiplinger
- 26 days ago - Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis - PRNewsWire
- 26 days ago - Abbott Laboratories: Investors Should Wait For A Pullback - Seeking Alpha